
Willie J. Daniel Jr.
Examiner (ID: 12204, Phone: (571)272-7907 , Office: P/2462 )
| Most Active Art Unit | 2462 |
| Art Unit(s) | 2462, 2465, 2641, 2617, 2686 |
| Total Applications | 889 |
| Issued Applications | 433 |
| Pending Applications | 99 |
| Abandoned Applications | 374 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16627356
[patent_doc_number] => 20210046009
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-18
[patent_title] => PROTECTING ORAL OVERDOSE WITH ABUSE DETERRENT IMMEDIATE RELEASE FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 17/086702
[patent_app_country] => US
[patent_app_date] => 2020-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32739
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 217
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17086702
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/086702 | PROTECTING ORAL OVERDOSE WITH ABUSE DETERRENT IMMEDIATE RELEASE FORMULATIONS | Nov 1, 2020 | Abandoned |
Array
(
[id] => 16627340
[patent_doc_number] => 20210045993
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-18
[patent_title] => COSMETIC COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/085166
[patent_app_country] => US
[patent_app_date] => 2020-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17820
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17085166
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/085166 | COSMETIC COMPOSITIONS | Oct 29, 2020 | Abandoned |
Array
(
[id] => 18056330
[patent_doc_number] => 20220387416
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-08
[patent_title] => ATROPINE-SCOPOLAMINE WITH ENHANCED STABILITY
[patent_app_type] => utility
[patent_app_number] => 17/755055
[patent_app_country] => US
[patent_app_date] => 2020-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8183
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17755055
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/755055 | ATROPINE-SCOPOLAMINE WITH ENHANCED STABILITY | Oct 25, 2020 | Pending |
Array
(
[id] => 16776498
[patent_doc_number] => 20210113575
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-22
[patent_title] => PHARMACEUTICAL COMPOSITIONS COMPRISING (S)-2-(2,6-DIOXOPIPERIDIN-3-YL)-4-((2-FLUORO-4-((3-MORPHOLINOAZETIDIN-1-YL)METHYL)BENZYL)AMINO)ISOINDOLINE-1,3-DIONE AND METHODS OF USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/075447
[patent_app_country] => US
[patent_app_date] => 2020-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27482
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -44
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17075447
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/075447 | Pharmaceutical compositions comprising (S)-2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dione and methods of using the same | Oct 19, 2020 | Issued |
Array
(
[id] => 16776382
[patent_doc_number] => 20210113459
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-22
[patent_title] => CHEWABLE GEL FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 17/073068
[patent_app_country] => US
[patent_app_date] => 2020-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6520
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17073068
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/073068 | CHEWABLE GEL FORMULATIONS | Oct 15, 2020 | Abandoned |
Array
(
[id] => 16596731
[patent_doc_number] => 20210023262
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-28
[patent_title] => COMPOSITION AND DRESSING WITH NITRIC OXIDE
[patent_app_type] => utility
[patent_app_number] => 17/068297
[patent_app_country] => US
[patent_app_date] => 2020-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10388
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17068297
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/068297 | COMPOSITION AND DRESSING WITH NITRIC OXIDE | Oct 11, 2020 | Abandoned |
Array
(
[id] => 18970529
[patent_doc_number] => 20240050621
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-15
[patent_title] => OCULAR SEALANTS AND METHODS OF USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/766445
[patent_app_country] => US
[patent_app_date] => 2020-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11748
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17766445
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/766445 | OCULAR SEALANTS AND METHODS OF USING THE SAME | Oct 7, 2020 | Pending |
Array
(
[id] => 16762580
[patent_doc_number] => 20210108161
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-15
[patent_title] => SANITISING COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/063325
[patent_app_country] => US
[patent_app_date] => 2020-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8030
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17063325
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/063325 | SANITISING COMPOSITION | Oct 4, 2020 | Abandoned |
Array
(
[id] => 19402035
[patent_doc_number] => 20240285546
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-29
[patent_title] => TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING AGOMELATINE
[patent_app_type] => utility
[patent_app_number] => 17/786217
[patent_app_country] => US
[patent_app_date] => 2020-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32399
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17786217
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/786217 | TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING AGOMELATINE | Oct 1, 2020 | Pending |
Array
(
[id] => 18706732
[patent_doc_number] => 20230329304
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-19
[patent_title] => METABOLIC THERAPY OF CANCER
[patent_app_type] => utility
[patent_app_number] => 18/025229
[patent_app_country] => US
[patent_app_date] => 2020-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13720
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18025229
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/025229 | METABOLIC THERAPY OF CANCER | Sep 22, 2020 | Pending |
Array
(
[id] => 17480493
[patent_doc_number] => 20220087997
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => Oral Antagonist Compositions For Nicotine Burning Relief
[patent_app_type] => utility
[patent_app_number] => 17/028002
[patent_app_country] => US
[patent_app_date] => 2020-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24316
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17028002
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/028002 | Oral Antagonist Compositions For Nicotine Burning Relief | Sep 21, 2020 | Pending |
Array
(
[id] => 16539339
[patent_doc_number] => 20200405752
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-31
[patent_title] => ANTITUMOR AGENT, ANTITUMOR EFFECT ENHANCER, AND ANTITUMOR KIT
[patent_app_type] => utility
[patent_app_number] => 17/018413
[patent_app_country] => US
[patent_app_date] => 2020-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12252
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17018413
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/018413 | ANTITUMOR AGENT, ANTITUMOR EFFECT ENHANCER, AND ANTITUMOR KIT | Sep 10, 2020 | Pending |
Array
(
[id] => 16539252
[patent_doc_number] => 20200405665
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-31
[patent_title] => METHODS FOR THE TREATMENT OF ROSACEA
[patent_app_type] => utility
[patent_app_number] => 17/016542
[patent_app_country] => US
[patent_app_date] => 2020-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9211
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17016542
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/016542 | METHODS FOR THE TREATMENT OF ROSACEA | Sep 9, 2020 | Abandoned |
Array
(
[id] => 16523689
[patent_doc_number] => 20200397769
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-24
[patent_title] => STABLE NIMODIPINE PARENTERAL FORMULATION
[patent_app_type] => utility
[patent_app_number] => 17/014276
[patent_app_country] => US
[patent_app_date] => 2020-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12509
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17014276
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/014276 | STABLE NIMODIPINE PARENTERAL FORMULATION | Sep 7, 2020 | Abandoned |
Array
(
[id] => 17843720
[patent_doc_number] => 11433062
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-09-06
[patent_title] => Stable nimodipine parenteral formulation
[patent_app_type] => utility
[patent_app_number] => 17/011345
[patent_app_country] => US
[patent_app_date] => 2020-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 9
[patent_no_of_words] => 11580
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17011345
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/011345 | Stable nimodipine parenteral formulation | Sep 2, 2020 | Issued |
Array
(
[id] => 17911425
[patent_doc_number] => 20220313820
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-06
[patent_title] => ULTRASOUND-ASSISTED DRUG DELIVERY CARRIER USING ULTRASOUND CONTRAST AGENT CONTAINING LIGAND CONJUGATED WITH DRUG THROUGH ESTER BOND
[patent_app_type] => utility
[patent_app_number] => 17/424485
[patent_app_country] => US
[patent_app_date] => 2020-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6745
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17424485
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/424485 | ULTRASOUND-ASSISTED DRUG DELIVERY CARRIER USING ULTRASOUND CONTRAST AGENT CONTAINING LIGAND CONJUGATED WITH DRUG THROUGH ESTER BOND | Aug 26, 2020 | Pending |
Array
(
[id] => 17648403
[patent_doc_number] => 11351102
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-07
[patent_title] => Plant actives and their anti-pollution effects thereof
[patent_app_type] => utility
[patent_app_number] => 17/003760
[patent_app_country] => US
[patent_app_date] => 2020-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 24
[patent_no_of_words] => 8826
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17003760
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/003760 | Plant actives and their anti-pollution effects thereof | Aug 25, 2020 | Issued |
Array
(
[id] => 17944210
[patent_doc_number] => 20220331227
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-20
[patent_title] => MICROCAPSULE AND HAIR CARE COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/639385
[patent_app_country] => US
[patent_app_date] => 2020-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6395
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17639385
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/639385 | Microcapsule and hair care composition | Aug 24, 2020 | Issued |
Array
(
[id] => 17897308
[patent_doc_number] => 20220306970
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-29
[patent_title] => IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/632971
[patent_app_country] => US
[patent_app_date] => 2020-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6910
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17632971
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/632971 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Aug 20, 2020 | Pending |
Array
(
[id] => 16481588
[patent_doc_number] => 20200375188
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-03
[patent_title] => Compositions, Methods and Uses for Cleaning, Disinfecting and/or Sterilizing
[patent_app_type] => utility
[patent_app_number] => 16/994847
[patent_app_country] => US
[patent_app_date] => 2020-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 82402
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16994847
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/994847 | Compositions, methods and uses for cleaning, disinfecting and/or sterilizing | Aug 16, 2020 | Issued |